廣和通(300638.SZ):兩名高管已合計減持62.4萬股
格隆匯11月12日丨廣和通(300638.SZ)公佈,公司於2020年11月10日收到公司董事、副總經理許寧及副總經理、董事會祕書陳仕江發出的《股份減持計劃實施進展通知》,獲悉此次許寧股份減持計劃中減持數量已過半、陳仕江股份減持計劃已實施完畢。
其中,許寧於2020年9月10日-11月10日期間通過集中競價方式減持公司股份61.39萬股,佔公司總股本的0.2542%;陳仕江於2020年11月10日通過集中競價方式減持公司股份1.0125萬股,佔公司總股本的0.0042%。二人合計減持62.4025萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.